Literature DB >> 28818679

Improved Assays for AGG Interruptions in Fragile X Premutation Carriers.

Bruce E Hayward1, Karen Usdin2.   

Abstract

The learning disability fragile X syndrome results from the presence of >200 CGG/CCG repeats in exon 1 of the X-linked gene FMR1. Such alleles arise by expansion from maternally transmitted FMR1 premutation alleles, alleles having 55 to 200 repeats. Expansion risk is directly related to maternal repeat number. However, AGG interruptions to the repeat tract are important modifiers of expansion risk. Thus, the ability to identify such interruptions is crucial for the appropriate genetic counseling of females who are premutation carriers. First-generation triplet-primed PCR assays allow these interruptions to be detected. However, because the triplet primer used has multiple binding sites in the repeat tract, interpreting the results is not straightforward and it is not always possible to unambiguously determine the AGG-interruption status in females because of the difficulties associated with the presence of a second X chromosome. Interpretation is further complicated by any repeat size mosaicism that may be present. We have developed second-generation PCR assays that prime specifically at the interruptions. These assays are simpler to interpret and better able to evaluate this important determinant of expansion risk in females even in those with a mixture of premutation allele sizes. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28818679      PMCID: PMC5807927          DOI: 10.1016/j.jmoldx.2017.06.008

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  11 in total

1.  Chemical synthesis of the mouse mitochondrial genome.

Authors:  Daniel G Gibson; Hamilton O Smith; Clyde A Hutchison; J Craig Venter; Chuck Merryman
Journal:  Nat Methods       Date:  2010-10-10       Impact factor: 28.547

2.  Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype.

Authors:  T C Falik-Zaccai; E Shachak; M Yalon; Z Lis; Z Borochowitz; J N Macpherson; D L Nelson; E E Eichler
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

3.  A Set of Assays for the Comprehensive Analysis of FMR1 Alleles in the Fragile X-Related Disorders.

Authors:  Bruce E Hayward; Yifan Zhou; Daman Kumari; Karen Usdin
Journal:  J Mol Diagn       Date:  2016-08-12       Impact factor: 5.568

4.  Length of uninterrupted CGG repeats determines instability in the FMR1 gene.

Authors:  E E Eichler; J J Holden; B W Popovich; A L Reiss; K Snow; S N Thibodeau; C S Richards; P A Ward; D L Nelson
Journal:  Nat Genet       Date:  1994-09       Impact factor: 38.330

5.  Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles.

Authors:  Sarah L Nolin; Sachin Sah; Anne Glicksman; Stephanie L Sherman; Emily Allen; Elizabeth Berry-Kravis; Flora Tassone; Carolyn Yrigollen; Amy Cronister; Marcia Jodah; Nicole Ersalesi; Carl Dobkin; W Ted Brown; Raghav Shroff; Gary J Latham; Andrew G Hadd
Journal:  Am J Med Genet A       Date:  2013-02-26       Impact factor: 2.802

6.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations.

Authors:  Flora Tassone; Ruiqin Pan; Khaled Amiri; Annette K Taylor; Paul J Hagerman
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

7.  AGG interruptions within the maternal FMR1 gene reduce the risk of offspring with fragile X syndrome.

Authors:  Carolyn M Yrigollen; Blythe Durbin-Johnson; Louise Gane; David L Nelson; Randi Hagerman; Paul J Hagerman; Flora Tassone
Journal:  Genet Med       Date:  2012-04-12       Impact factor: 8.822

Review 8.  The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspective.

Authors:  Gary J Latham; Justine Coppinger; Andrew G Hadd; Sarah L Nolin
Journal:  Front Genet       Date:  2014-07-29       Impact factor: 4.599

9.  AGG interruptions and maternal age affect FMR1 CGG repeat allele stability during transmission.

Authors:  Carolyn M Yrigollen; Loreto Martorell; Blythe Durbin-Johnson; Montserrat Naudo; Jordi Genoves; Alessandra Murgia; Roberta Polli; Lili Zhou; Deborah Barbouth; Abigail Rupchock; Brenda Finucane; Gary J Latham; Andrew Hadd; Elizabeth Berry-Kravis; Flora Tassone
Journal:  J Neurodev Disord       Date:  2014-07-30       Impact factor: 4.025

10.  Fragile X full mutation expansions are inhibited by one or more AGG interruptions in premutation carriers.

Authors:  Sarah L Nolin; Anne Glicksman; Nicole Ersalesi; Carl Dobkin; W Ted Brown; Ru Cao; Eliot Blatt; Sachin Sah; Gary J Latham; Andrew G Hadd
Journal:  Genet Med       Date:  2014-09-11       Impact factor: 8.822

View more
  5 in total

Review 1.  Recent advances in assays for the fragile X-related disorders.

Authors:  Bruce E Hayward; Daman Kumari; Karen Usdin
Journal:  Hum Genet       Date:  2017-09-02       Impact factor: 4.132

2.  Fragile X syndrome in a male with methylated premutation alleles and no detectable methylated full mutation alleles.

Authors:  Bruce Hayward; Inna Loutaev; Xiaohua Ding; Sarah L Nolin; Audrey Thurm; Karen Usdin; Carolyn B Smith
Journal:  Am J Med Genet A       Date:  2019-07-29       Impact factor: 2.578

3.  Assays for Determining Repeat Number, Methylation Status, and AGG Interruptions in the Fragile X-Related Disorders.

Authors:  Bruce E Hayward; Karen Usdin
Journal:  Methods Mol Biol       Date:  2019

Review 4.  Single molecule real-time (SMRT) sequencing comes of age: applications and utilities for medical diagnostics.

Authors:  Simon Ardui; Adam Ameur; Joris R Vermeesch; Matthew S Hestand
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

5.  Detecting AGG Interruptions in Females With a FMR1 Premutation by Long-Read Single-Molecule Sequencing: A 1 Year Clinical Experience.

Authors:  Simon Ardui; Valerie Race; Thomy de Ravel; Hilde Van Esch; Koenraad Devriendt; Gert Matthijs; Joris R Vermeesch
Journal:  Front Genet       Date:  2018-05-16       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.